1. Home
  2. NVO
  3. NVO News

Latest Novo Nordisk A/S (NVO) News on September 15, 2025

This Under-the-Radar Healthcare Stock Could Soar in 2026
NVO

Motley Fool

3 days ago

This Under-the-Radar Healthcare Stock Could Soar in 2026

Prescription Drug Ads Face Big Changes. These Stocks Could Get Hurt the Most.
NVO

Barrons.com

4 days ago

Prescription Drug Ads Face Big Changes. These Stocks Could Get Hurt the Most.

Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback
NVO

Motley Fool

4 days ago

Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback

NVO

MT Newswires

4 days ago

Sector Update: Health Care Stocks Higher Thursday Afternoon

NVO

MT Newswires

4 days ago

Update: Market Chatter: Novo Nordisk to Require Workers to Return to Office 5 Days a Week

Novo Nordisk issues return to office policy after layoffs
NVO

Quartz

4 days ago

Novo Nordisk issues return to office policy after layoffs

Where Does VKTX Stock Stand After the Obesity Pill Setback?
NVO

Zacks

4 days ago

Where Does VKTX Stock Stand After the Obesity Pill Setback?

Prothena Down 40% Year to Date: What Lies Ahead for the Stock?
NVO

Zacks

4 days ago

Prothena Down 40% Year to Date: What Lies Ahead for the Stock?

Novo Nordisk tells staff to return to office full-time amid CEO's revival effort
NVO

Reuters

4 days ago

Novo Nordisk tells staff to return to office full-time amid CEO's revival effort

NVO

MT Newswires

4 days ago

Market Chatter: Novo Nordisk to Require Workers to Return to Office 5 Days a Week

Health Care Roundup: Market Talk
NVO

The Wall Street Journal

4 days ago

Health Care Roundup: Market Talk

2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades
NVO

Motley Fool

4 days ago

2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades

Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets
NVO

Benzinga

5 days ago

Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets

Novo Nordisk Stock Rises as Investors Cheer 9,000 Job Cuts Despite Guidance Cut
NVO

GuruFocus.com

5 days ago

Novo Nordisk Stock Rises as Investors Cheer 9,000 Job Cuts Despite Guidance Cut

NVO

Reuters

5 days ago

Rate of employers covering weight-loss drugs is flat, Cigna says

Novo Nordisk Tightens Its Belt, Cutting 9,000 Jobs And Its Profit Outlook
NVO

Investor's Business Daily

5 days ago

Novo Nordisk Tightens Its Belt, Cutting 9,000 Jobs And Its Profit Outlook

Synopsys China slowdown, Novo Nordisk job cuts, Chewy earnings
NVO

Yahoo Finance Video

5 days ago

Synopsys China slowdown, Novo Nordisk job cuts, Chewy earnings

Wegovy and Ozempic maker to cut 9,000 jobs amid stiff competition from Eli Lilly
NVO

CNN Business

5 days ago

Wegovy and Ozempic maker to cut 9,000 jobs amid stiff competition from Eli Lilly

5 Things to Know Before the Stock Market Opens
NVO

Investopedia

5 days ago

5 Things to Know Before the Stock Market Opens

Novo Nordisk slashes 11% of workforce as Eli Lilly pressure tightens
NVO

Pharmaceutical Technology

5 days ago

Novo Nordisk slashes 11% of workforce as Eli Lilly pressure tightens

Wegovy maker Novo Nordisk says it's cutting 9,000 workers
NVO

CBS News

5 days ago

Wegovy maker Novo Nordisk says it's cutting 9,000 workers

Novo Nordisk Cuts 9,000 Jobs and Slashes Guidance. Why the Stock Is Rising.
NVO

Barrons.com

5 days ago

Novo Nordisk Cuts 9,000 Jobs and Slashes Guidance. Why the Stock Is Rising.

Ozempic maker Novo Nordisk to cut 9,000 global jobs
NVO

AFP

5 days ago

Ozempic maker Novo Nordisk to cut 9,000 global jobs

1 Reason Every Investor Should Know About Novo Nordisk (NVO)
NVO

Motley Fool

6 days ago

1 Reason Every Investor Should Know About Novo Nordisk (NVO)

WHO adds GLP-1RAs to essential medicines list
NVO

Pharmaceutical Technology

7 days ago

WHO adds GLP-1RAs to essential medicines list

NVO

MT Newswires

7 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

Could Gut Microbiome Research Shift Novozymes' Innovation Narrative in Health and Nutrition (CPSE:NSIS B)?
NVO

Simply Wall St.

7 days ago

Could Gut Microbiome Research Shift Novozymes' Innovation Narrative in Health and Nutrition (CPSE:NSIS B)?

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health
NVO

GlobeNewswire

7 days ago

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health

Novo Nordisk (NYSE:NVO): Assessing Valuation After Recent Share Price Swings
NVO

Simply Wall St.

8 days ago

Novo Nordisk (NYSE:NVO): Assessing Valuation After Recent Share Price Swings

NVO

MT Newswires

10 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

WHO adds weight loss drugs to essential medicines list
NVO

Quartz

10 days ago

WHO adds weight loss drugs to essential medicines list

NVO

MT Newswires

10 days ago

Sector Update: Health Care Stocks Rise Friday Afternoon

NVO

MT Newswires

10 days ago

European Equities Traded in the US as ADRs Are Little Changed in Friday Trading

Jefferies Sees Huge Potential in Eli Lilly’s (LLY) New Weight-Loss Pill
NVO

Insider Monkey

10 days ago

Jefferies Sees Huge Potential in Eli Lilly’s (LLY) New Weight-Loss Pill

NVO

MT Newswires

10 days ago

World Health Organization Adds Ozempic, Mounjaro to Essential Medicines List

EMA warns of rise in illegal weight loss drugs marketed online
NVO

Pharmaceutical Technology

10 days ago

EMA warns of rise in illegal weight loss drugs marketed online

Why weight-loss 'wonder drugs' aren't 'wonder stocks' — yet
NVO

Yahoo Finance

10 days ago

Why weight-loss 'wonder drugs' aren't 'wonder stocks' — yet

Down 34%, Should You Buy the Dip on Viking Therapeutics?
NVO

Motley Fool

10 days ago

Down 34%, Should You Buy the Dip on Viking Therapeutics?

Novo Nordisk to present new semaglutide data on ‘food noise’, body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress
NVO

GlobeNewswire

10 days ago

Novo Nordisk to present new semaglutide data on ‘food noise’, body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress

Novo Slowdown to Hurt Danish GDP, Central Bank Governor Says
NVO

Bloomberg

10 days ago

Novo Slowdown to Hurt Danish GDP, Central Bank Governor Says

NVO

MT Newswires

11 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

TEVA Stock Up More Than 19% in a Month: Buy, Sell or Hold the Stock?
NVO

Zacks

11 days ago

TEVA Stock Up More Than 19% in a Month: Buy, Sell or Hold the Stock?

NVO

Investing.com

12 days ago

Hims & Hers gains after court rejects Eli Lilly’s case against Willow

Stocks to Watch Recap: Alphabet, Nvidia, Comerica, Constellation Brands
NVO

The Wall Street Journal

13 days ago

Stocks to Watch Recap: Alphabet, Nvidia, Comerica, Constellation Brands

NVO

MT Newswires

13 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

NVO

MT Newswires

13 days ago

Sector Update: Health Care

Chinese drugmakers prep for looming semaglutide generics horizon
NVO

Pharmaceutical Technology

13 days ago

Chinese drugmakers prep for looming semaglutide generics horizon

ESC 2025: real-world evidence shows efficacy of semaglutide in Swiss T2D patients
NVO

Clinical Trials Arena

13 days ago

ESC 2025: real-world evidence shows efficacy of semaglutide in Swiss T2D patients

UBS Maintains a Hold on Novo Nordisk (NVO)
NVO

Insider Monkey

13 days ago

UBS Maintains a Hold on Novo Nordisk (NVO)

NVO

MT Newswires

13 days ago

Novo Nordisk Gets Backing From Denmark's Pension Fund

Viking Therapeutics Loses 20% in a Month: How to Play the Stock
NVO

Zacks

13 days ago

Viking Therapeutics Loses 20% in a Month: How to Play the Stock

Constellation Brands, Novo Nordisk, Klarna IPO: Trending Tickers
NVO

Yahoo Finance Video

13 days ago

Constellation Brands, Novo Nordisk, Klarna IPO: Trending Tickers

Stocks to Watch Tuesday: Nvidia, Eli Lilly, PepsiCo
NVO

The Wall Street Journal

13 days ago

Stocks to Watch Tuesday: Nvidia, Eli Lilly, PepsiCo

What Makes Novo Nordisk A/S (NVO) an Attractive Investment Compared to Competitors?
NVO

Insider Monkey

13 days ago

What Makes Novo Nordisk A/S (NVO) an Attractive Investment Compared to Competitors?

Novo Nordisk's Wegovy Outshines Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke And Death
NVO

Benzinga

13 days ago

Novo Nordisk's Wegovy Outshines Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke And Death

NVO

MT Newswires

13 days ago

Update: Market Chatter: Novo Nordisk Cancels New Hire Contracts in Denmark Amid Cost Cuts

Chinese companies turn to generics as shipments behind US weight-loss craze fade
NVO

Reuters

13 days ago

Chinese companies turn to generics as shipments behind US weight-loss craze fade

NVO

MT Newswires

13 days ago

Novo Nordisk Says Wegovy Study Showed 57% Heart Attack Reduction Compared With Tirzepatide

NVO

Financial Times

13 days ago

Software becomes the next frontier for building quantum computers

Novo Nordisk (NVO) Jumps as Wegovy Beats Eli Lilly in Cardiovascular Outcomes
NVO

GuruFocus.com

14 days ago

Novo Nordisk (NVO) Jumps as Wegovy Beats Eli Lilly in Cardiovascular Outcomes

ESC 2025: Novo Nordisk’s Wegovy superior to Zepbound in reducing CV events
NVO

Pharmaceutical Technology

14 days ago

ESC 2025: Novo Nordisk’s Wegovy superior to Zepbound in reducing CV events

ESC 2025: Study supports use of semaglutide, tirzepatide in cardiometabolic HFpEF patients
NVO

Clinical Trials Arena

14 days ago

ESC 2025: Study supports use of semaglutide, tirzepatide in cardiometabolic HFpEF patients

European stock markets are up, Novo Nordisk is among the winners
NVO

Euronews

14 days ago

European stock markets are up, Novo Nordisk is among the winners

Novo’s Wegovy Beats Lilly’s Zepbound for Heart Health, Study Finds. What It Means for Stocks.
NVO

Barrons.com

14 days ago

Novo’s Wegovy Beats Lilly’s Zepbound for Heart Health, Study Finds. What It Means for Stocks.

Novo Nordisk Says Wegovy Cuts Heart Risk by 57% Compared With Eli Lilly’s Obesity Drug
NVO

The Wall Street Journal

14 days ago

Novo Nordisk Says Wegovy Cuts Heart Risk by 57% Compared With Eli Lilly’s Obesity Drug

Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease
NVO

GlobeNewswire

15 days ago

Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease

Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas
NVO

GlobeNewswire

15 days ago

Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas

Novo Nordisk's Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease
NVO

PR Newswire

15 days ago

Novo Nordisk's Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease

Novo Nordisk (NVO) Gains Momentum With Strong Earnings and Wegovy FDA Approval
NVO

Insider Monkey

15 days ago

Novo Nordisk (NVO) Gains Momentum With Strong Earnings and Wegovy FDA Approval

Leerink Partners Reiterates a Buy Rating on GoodRx Holdings (GDRX) With a $6 PT
NVO

Insider Monkey

15 days ago

Leerink Partners Reiterates a Buy Rating on GoodRx Holdings (GDRX) With a $6 PT

NVO

MT Newswires

17 days ago

Sector Update: Health Care Stocks Higher Late Afternoon

NVO

MT Newswires

17 days ago

Sector Update: Health Care Stocks Advance Friday Afternoon

Teva brings first generic GLP-1 to US market with Saxenda copycat approval
NVO

Pharmaceutical Technology

17 days ago

Teva brings first generic GLP-1 to US market with Saxenda copycat approval

NVO

MT Newswires

17 days ago

Market Chatter: Novo Nordisk Cancels New Hire Contracts in Denmark Amid Cost Cuts

How Novo Nordisk Hurt Denmark’s Economy
NVO

Barrons.com

17 days ago

How Novo Nordisk Hurt Denmark’s Economy

FDA Approves First-Ever Generic Weight-Loss Drug In A Blow To Novo Nordisk
NVO

Investor's Business Daily

18 days ago

FDA Approves First-Ever Generic Weight-Loss Drug In A Blow To Novo Nordisk

Novo Nordisk enlists srRNA developer Replicate in $550m deal
NVO

Pharmaceutical Technology

18 days ago

Novo Nordisk enlists srRNA developer Replicate in $550m deal

Despite Early Low Awareness, Physicians Forecast Swift Adoption of Novo Nordisk’s Wegovy in MASH, According to Spherix Global Insights
NVO

GlobeNewswire

18 days ago

Despite Early Low Awareness, Physicians Forecast Swift Adoption of Novo Nordisk’s Wegovy in MASH, According to Spherix Global Insights

Novo Nordisk Eyes New Arena Amid Weight-Loss Market Pressure
NVO

Investor's Business Daily

18 days ago

Novo Nordisk Eyes New Arena Amid Weight-Loss Market Pressure

Replicate Bioscience Announces Partnership with Novo Nordisk to Unlock Self-Replicating RNA Therapies for Obesity and Diabetes
NVO

PR Newswire

18 days ago

Replicate Bioscience Announces Partnership with Novo Nordisk to Unlock Self-Replicating RNA Therapies for Obesity and Diabetes

Novo strikes RNA drug deal with startup Replicate
NVO

BioPharma Dive

18 days ago

Novo strikes RNA drug deal with startup Replicate

2 Dividend Stocks to Hold for the Next 10 Years
NVO

Motley Fool

18 days ago

2 Dividend Stocks to Hold for the Next 10 Years

2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
NVO

Motley Fool

18 days ago

2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade

NVO

Oilprice.com

18 days ago

NVIDIA Q2 Profit Soars 59% as Blackwell AI Surge Fuels Record Revenue

NVIDIA Announces Financial Results for Second Quarter Fiscal 2026
NVO

GlobeNewswire

19 days ago

NVIDIA Announces Financial Results for Second Quarter Fiscal 2026

Why GoodRx (GDRX) Stock Is Up Today
NVO

StockStory

19 days ago

Why GoodRx (GDRX) Stock Is Up Today

NVO

MT Newswires

19 days ago

Eli Lilly's Late-Stage Study on Weight-Loss Pill Shows 'Clear Positive,' Improved Commercial Outlook, UBS Says

NVO

Investing.com

19 days ago

HSBC upgrades Eli Lilly to Hold, says ’bear case has played out’

9amHealth Teams Up with Novo Nordisk to Expand Access to Evidence-Based Virtual Obesity Care Nationwide
NVO

PR Newswire

19 days ago

9amHealth Teams Up with Novo Nordisk to Expand Access to Evidence-Based Virtual Obesity Care Nationwide

Form Health Selected for Novo Nordisk’s NovoCare® Platform to Expand Access to Science-Based Obesity Care Across the United States
NVO

Business Wire

19 days ago

Form Health Selected for Novo Nordisk’s NovoCare® Platform to Expand Access to Science-Based Obesity Care Across the United States

Does Lilly's New Obesity Pill Data Put It Back in the Weight Game?
NVO

Zacks

19 days ago

Does Lilly's New Obesity Pill Data Put It Back in the Weight Game?

LLY vs. PFE: Which Pharma Giant Is the Better Pick for Investors?
NVO

Zacks

19 days ago

LLY vs. PFE: Which Pharma Giant Is the Better Pick for Investors?

A brewing GLP-1 showdown, from Big Pharma pills to a biotech implant
NVO

Pharma Voice

19 days ago

A brewing GLP-1 showdown, from Big Pharma pills to a biotech implant

Novo Nordisk Recieves an Upgrade From DBS, Price Cut From TD Cowen
NVO

Insider Monkey

19 days ago

Novo Nordisk Recieves an Upgrade From DBS, Price Cut From TD Cowen

Why Novo Nordisk Stock Tumbled on Tuesday
NVO

Motley Fool

20 days ago

Why Novo Nordisk Stock Tumbled on Tuesday

Eli Lilly’s weight-loss pill meets target in key diabetes trial
NVO

Financial Times

20 days ago

Eli Lilly’s weight-loss pill meets target in key diabetes trial

Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump
NVO

Investor's Business Daily

20 days ago

Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump

AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock?
NVO

Zacks

20 days ago

AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock?

Eli Lilly Says New Pill Results in 10.5% Weight-Loss for Diabetes Patients. The Stock Is Up.
NVO

Barrons.com

20 days ago

Eli Lilly Says New Pill Results in 10.5% Weight-Loss for Diabetes Patients. The Stock Is Up.

TD Cowen Lowers PT on Novo Nordisk (NVO), Keeps a Buy
NVO

Insider Monkey

20 days ago

TD Cowen Lowers PT on Novo Nordisk (NVO), Keeps a Buy

Share on Social Networks: